Company Profile LogoITeos Therapeutics

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

Edit IconSuggest an Edit
Medical
Health Care
Biotechnology

    Unlock insights on ITeos Therapeutics and 60M+ companies now!

    ITeos Therapeutics Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

    ITeos Therapeutics is a private biotechnology company targeting the metabolism of the tumor microenvironment to develop small molecule immunomodulators for cancer treatments. iTeos is building its activities upon the unparalleled expertise of the Ludwig Cancer Research (LICR) – a world-class Research Institute in the fields of tumor immunology, therapeutic cancer vaccines, cancer biology, and translational medicine in cancer. iTeos endeavors to develop small molecules designed to target the tum

    Repeat Founder
    Company Highlights
    Year Founded

    2011

    icon-altEmployees

    183

    Location (HQ)

    USA

    Since Last Funding

    6 months

    Monthly Website Visitors

    4.0K

    icon-altTotal Investment Amt

    $400M

    Last Funding Round

    Post Ipo Equity

    icon-altMoM Headcount Growth

    -0.54%

    icon-altYoY Headcount Growth

    11.58%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Health Care

    Biotechnology

    Biotechnology Research

    Medical